Date published: 2026-3-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOXL3 Inhibitors

The chemical class referred to as LOXL3 inhibitors comprises a diverse group of organic molecules and synthetic compounds that are that target and modulate the enzymatic activity of Lysyl oxidase-like 3 (LOXL3), a member of the lysyl oxidase (LOX) enzyme family. LOXL3 is involved in catalyzing the crosslinking of collagen and elastin fibers within the extracellular matrix. These inhibitors are developed using rational drug design strategies, often informed by structural insights into the LOXL3 enzyme and its catalytic mechanisms. By interacting with specific binding sites or active sites on LOXL3, these inhibitors aim to disrupt its enzymatic function, potentially influencing extracellular matrix dynamics.

The chemical structures of LOXL3 inhibitors exhibit diversity, incorporating various molecular frameworks and arrangements. Through their tailored interactions with LOXL3, these inhibitors serve as valuable tools for advancing scientific understanding of the enzyme's biochemical activities and its potential roles in extracellular matrix remodeling processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

Zebularine, known for its DNA demethylation effects, has been investigated for its potential to inhibit LOXL3 and impact fibrosis-related processes.